Nat Commun:荧光标记的万古霉素可实时观测细菌感染

2013-11-01 Nature中文网 Nature中文网

荧光标记的万古霉素(一种用来治疗细菌感染的抗生素)可被用来检测动物的细菌感染和人类尸体中与生物材料相关的感染。发表在本期Nature Communications上的这项研究,代表着用来检测可能是由以移植物形式存在的生物材料引起的细菌感染的一种灵敏的、具有特异性的和非入侵式的方法。 Marleen van Oosten、Gooitzen van Dam、Jan Maarten van Dijl和

荧光标记的万古霉素(一种用来治疗细菌感染的抗生素)可被用来检测动物的细菌感染和人类尸体中与生物材料相关的感染。发表在本期Nature Communications上的这项研究,代表着用来检测可能是由以移植物形式存在的生物材料引起的细菌感染的一种灵敏的、具有特异性的和非入侵式的方法。【原文下载】

Marleen van Oosten、Gooitzen van Dam、Jan Maarten van Dijl和同事给感染了金黄色葡萄球菌的小鼠注射了一剂荧光标记的万古霉素。这个剂量要比用于人类、能产生治疗反应的剂量低几倍。第二天,他们能够用一种非入侵式实时光学成像方法确定这些动物身上的细菌感染点。他们还在一个人类尸体上测试了这种检测方法,该尸体在人死后接受了被感染的移植物。他们发现,仅仅采用荧光抗生素,就足以检测到浅层移植的医疗设备上的细菌。作者报告说,该方法还允许对由细菌感染引起的炎症与非细菌炎症进行区分。

这一方法具有潜在重要性,因为与生物材料相关的感染构成一个重要的临床负担,而迄今为止还没有用来对患者的这些感染进行检测的灵敏的、具有特异性的和非入侵式的方法。

原文出处:

Marleen van Oosten,Tina Schfer,Joost A. C. Gazendam,Knut Ohlsen,Eleni Tsompanidou,Marcus C. de Goffau,Hermie J. M. Harmsen,Lucia M. A. Crane,Ed Lim,Kevin P. Francis,Lael Cheung,Michael Olive,Vasilis Ntziachristos,Jan Maarten van Dijl& Gooitzen M. van Dam.Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin.Nat Commun. 2013;4:2584. doi: 10.1038/ncomms3584.【原文下载】

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1707739, encodeId=92c11e0773931, content=<a href='/topic/show?id=bd958e237a6' target=_blank style='color:#2F92EE;'>#荧光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87237, encryptionId=bd958e237a6, topicName=荧光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae2931492970, createdName=ms6897892027066920, createdTime=Wed Feb 05 16:29:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086663, encodeId=5b02208666337, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Nov 16 18:29:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879723, encodeId=a03618e97239f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jan 30 09:29:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6264, encodeId=f3ae6264f5, content=这种信息很重要,知道临床以及科研工作。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6680472, createdName=horror2001, createdTime=Mon Nov 04 22:15:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280634, encodeId=6bbc12806348c, content=<a href='/topic/show?id=beefe810798' target=_blank style='color:#2F92EE;'>#细菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78107, encryptionId=beefe810798, topicName=细菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Nov 03 00:29:00 CST 2013, time=2013-11-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1707739, encodeId=92c11e0773931, content=<a href='/topic/show?id=bd958e237a6' target=_blank style='color:#2F92EE;'>#荧光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87237, encryptionId=bd958e237a6, topicName=荧光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae2931492970, createdName=ms6897892027066920, createdTime=Wed Feb 05 16:29:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086663, encodeId=5b02208666337, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Nov 16 18:29:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879723, encodeId=a03618e97239f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jan 30 09:29:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6264, encodeId=f3ae6264f5, content=这种信息很重要,知道临床以及科研工作。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6680472, createdName=horror2001, createdTime=Mon Nov 04 22:15:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280634, encodeId=6bbc12806348c, content=<a href='/topic/show?id=beefe810798' target=_blank style='color:#2F92EE;'>#细菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78107, encryptionId=beefe810798, topicName=细菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Nov 03 00:29:00 CST 2013, time=2013-11-03, status=1, ipAttribution=)]
    2013-11-16 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1707739, encodeId=92c11e0773931, content=<a href='/topic/show?id=bd958e237a6' target=_blank style='color:#2F92EE;'>#荧光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87237, encryptionId=bd958e237a6, topicName=荧光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae2931492970, createdName=ms6897892027066920, createdTime=Wed Feb 05 16:29:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086663, encodeId=5b02208666337, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Nov 16 18:29:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879723, encodeId=a03618e97239f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jan 30 09:29:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6264, encodeId=f3ae6264f5, content=这种信息很重要,知道临床以及科研工作。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6680472, createdName=horror2001, createdTime=Mon Nov 04 22:15:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280634, encodeId=6bbc12806348c, content=<a href='/topic/show?id=beefe810798' target=_blank style='color:#2F92EE;'>#细菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78107, encryptionId=beefe810798, topicName=细菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Nov 03 00:29:00 CST 2013, time=2013-11-03, status=1, ipAttribution=)]
    2014-01-30 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1707739, encodeId=92c11e0773931, content=<a href='/topic/show?id=bd958e237a6' target=_blank style='color:#2F92EE;'>#荧光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87237, encryptionId=bd958e237a6, topicName=荧光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae2931492970, createdName=ms6897892027066920, createdTime=Wed Feb 05 16:29:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086663, encodeId=5b02208666337, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Nov 16 18:29:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879723, encodeId=a03618e97239f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jan 30 09:29:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6264, encodeId=f3ae6264f5, content=这种信息很重要,知道临床以及科研工作。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6680472, createdName=horror2001, createdTime=Mon Nov 04 22:15:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280634, encodeId=6bbc12806348c, content=<a href='/topic/show?id=beefe810798' target=_blank style='color:#2F92EE;'>#细菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78107, encryptionId=beefe810798, topicName=细菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Nov 03 00:29:00 CST 2013, time=2013-11-03, status=1, ipAttribution=)]
    2013-11-04 horror2001

    这种信息很重要,知道临床以及科研工作。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1707739, encodeId=92c11e0773931, content=<a href='/topic/show?id=bd958e237a6' target=_blank style='color:#2F92EE;'>#荧光#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87237, encryptionId=bd958e237a6, topicName=荧光)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae2931492970, createdName=ms6897892027066920, createdTime=Wed Feb 05 16:29:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086663, encodeId=5b02208666337, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Nov 16 18:29:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879723, encodeId=a03618e97239f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jan 30 09:29:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6264, encodeId=f3ae6264f5, content=这种信息很重要,知道临床以及科研工作。, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6680472, createdName=horror2001, createdTime=Mon Nov 04 22:15:00 CST 2013, time=2013-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280634, encodeId=6bbc12806348c, content=<a href='/topic/show?id=beefe810798' target=_blank style='color:#2F92EE;'>#细菌感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78107, encryptionId=beefe810798, topicName=细菌感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Sun Nov 03 00:29:00 CST 2013, time=2013-11-03, status=1, ipAttribution=)]

相关资讯

Nat Immuno:干扰素β/IFNAR1激活免疫机制

日前,来自澳洲莫纳什大学的科学家们通过研究获得了关于免疫反应早期阶段的新见解,这为从多发性硬化症到癌症等许多疾病开发治疗提供了一些新的途径。这项刊登在《自然免疫学》(Nature Immunology)杂志上的研究首次确定了,β干扰素(interferon beta, IFNβ)蛋白结合细胞并激活免疫反应的机制特征。 当身体检测到病毒或细菌感染时,干扰素β就会产生。对于身体的抵御能力来说,干

Nature:先天免疫系统蛋白或成为抵御细菌感染的新靶点

近日,来自St.Jude儿童研究医院的科学家发现了一种新的方法来有效抵御细菌的感染,这种方法通过以先天性的免疫系统组分为靶点,从而激活免疫效应。这项研究中研究者阐述了先天性免疫分子的主要功能是抑制炎症,反过来可以缓冲感染或者其它威胁产生的免疫效应。研究者揭示了蛋白质可以抑制两种途径,这两种途径可以控制特定分子的产生进而与感染进行“斗争”,相关研究成果刊登在了国际著名杂志Nature上。 研究者表